194 related articles for article (PubMed ID: 23289593)
1. Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity.
Peck Y; Wang DA
Expert Opin Drug Deliv; 2013 Mar; 10(3):369-83. PubMed ID: 23289593
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensionally engineered biomimetic cartilaginous tissue model for osteoarthritic drug evaluation.
Peck Y; Ng LY; Goh JY; Gao C; Wang DA
Mol Pharm; 2014 Jul; 11(7):1997-2008. PubMed ID: 24579704
[TBL] [Abstract][Full Text] [Related]
3. 3D bioprinting for drug discovery and development in pharmaceutics.
Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
[TBL] [Abstract][Full Text] [Related]
4. Application of 3D biomimetic models in drug delivery and regenerative medicine.
Xu Y; Wang X
Curr Pharm Des; 2015; 21(12):1618-26. PubMed ID: 25594404
[TBL] [Abstract][Full Text] [Related]
5. Tissue-engineered models of human tumors for cancer research.
Villasante A; Vunjak-Novakovic G
Expert Opin Drug Discov; 2015 Mar; 10(3):257-68. PubMed ID: 25662589
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
Nam KH; Smith AS; Lone S; Kwon S; Kim DH
J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
[TBL] [Abstract][Full Text] [Related]
7. Anticancer drug discovery using multicellular tumor spheroid models.
Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
[TBL] [Abstract][Full Text] [Related]
8. 3D Bioprinting of Tissue/Organ Models.
Pati F; Gantelius J; Svahn HA
Angew Chem Int Ed Engl; 2016 Apr; 55(15):4650-65. PubMed ID: 26895542
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional in vitro tumor models for cancer research and drug evaluation.
Xu X; Farach-Carson MC; Jia X
Biotechnol Adv; 2014 Nov; 32(7):1256-1268. PubMed ID: 25116894
[TBL] [Abstract][Full Text] [Related]
10. Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use.
Nichols JE; Niles JA; Vega SP; Argueta LB; Eastaway A; Cortiella J
Exp Biol Med (Maywood); 2014 Sep; 239(9):1135-69. PubMed ID: 24962174
[TBL] [Abstract][Full Text] [Related]
11. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
12. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Biomaterials for In Vitro Cancer Tissue Engineering and Drug Testing Applications.
Pradhan S; Hassani I; Clary JM; Lipke EA
Tissue Eng Part B Rev; 2016 Dec; 22(6):470-484. PubMed ID: 27302080
[TBL] [Abstract][Full Text] [Related]
14. Delivering bioactive molecules as instructive cues to engineered tissues.
Gabriel D; Dvir T; Kohane DS
Expert Opin Drug Deliv; 2012 Apr; 9(4):473-92. PubMed ID: 22432691
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Culture Systems and 3D Interfaces Models for Cancer Drugs Testing.
Fernandes DC; Canadas RF; Reis RL; Oliveira JM
Adv Exp Med Biol; 2020; 1230():137-159. PubMed ID: 32285369
[TBL] [Abstract][Full Text] [Related]
16. A preface for engineered biomimetic tissue platforms for in vitro drug evaluation.
Wang DA; Mahato RI
Mol Pharm; 2014 Jul; 11(7):1931-2. PubMed ID: 24998338
[No Abstract] [Full Text] [Related]
17. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
Loessner D; Holzapfel BM; Clements JA
Adv Drug Deliv Rev; 2014 Dec; 79-80():193-213. PubMed ID: 24969478
[TBL] [Abstract][Full Text] [Related]
18. Biomimetics in drug delivery systems: A critical review.
Sheikhpour M; Barani L; Kasaeian A
J Control Release; 2017 May; 253():97-109. PubMed ID: 28322976
[TBL] [Abstract][Full Text] [Related]
19. Two-Dimensional and Three-Dimensional Cartilage Model Platforms for Drug Evaluation and High-Throughput Screening Assays.
Foster NC; Hall NM; Haj AJE
Tissue Eng Part B Rev; 2022 Apr; 28(2):421-436. PubMed ID: 34010074
[TBL] [Abstract][Full Text] [Related]
20. A human osteoarthritis osteochondral organ culture model for cartilage tissue engineering.
Yeung P; Zhang W; Wang XN; Yan CH; Chan BP
Biomaterials; 2018 Apr; 162():1-21. PubMed ID: 29428675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
